Discovery of Additional Class of Novel Lipid Nanoparticles with Markedly Improved In Vivo Potency for RNAi Therapeutics

The new study employed a rational design approach for the discovery of novel lipids that can be incorporated into lipid nanoparticles (LNPs) for systemic delivery of RNAi therapeutics. This new research complements the combinatorial chemistry-based approach recently described by Alnylam scientists.

Related Posts

Comments are closed.